1. NIPGR Digital Knowledge Repository (NDKR)
  2. Publications of NIPGR Scientists
  3. Institutional Publications
Please use this identifier to cite or link to this item: http://223.31.159.10:8080/jspui/handle/123456789/1062
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPrasad, Ashish-
dc.contributor.authorPrasad, Manoj-
dc.date.accessioned2020-05-13T10:59:25Z-
dc.date.available2020-05-13T10:59:25Z-
dc.date.issued2020-
dc.identifier.citationJournal of Genetics, 99(1): 37en_US
dc.identifier.issn0973-7731-
dc.identifier.otherhttps://doi.org/10.1007/s12041-020-01205-x-
dc.identifier.urihttps://link.springer.com/article/10.1007/s12041-020-01205-x-
dc.identifier.urihttp://223.31.159.10:8080/jspui/handle/123456789/1062-
dc.descriptionAccepted date: 11 April 2020en_US
dc.description.abstractCoronavirus disease 2019 was first reported from Wuhan district of China and has spread to 210 countries across the world claiming over 97,602 human lives as on 10 April 2020 by 21:06 pm. Currently, there is no specific treatment for this virus and the treatment is mainly relied on controlling symptoms. Here we discuss our current understanding of SARS-CoV-2 with respect to its receptor recognition and how this knowledge could be useful in treatement using clinically known inhibitory drugs. We have also discussed the diagnosis, treatment and preventive measures that are currently being employed for controlling further spread of the virus.en_US
dc.language.isoen_USen_US
dc.publisherSpringer Nature Switzerland AGen_US
dc.subjectSARS-CoV-2en_US
dc.subjectviral pathogenen_US
dc.subjectepidemicen_US
dc.subjectpandemicen_US
dc.subjectcoronavirusen_US
dc.subjecthuman healthen_US
dc.subjectcovid19en_US
dc.titleSARS-CoV-2: the emergence of a viral pathogen causing havoc on human existenceen_US
dc.typeArticleen_US
Appears in Collections:Institutional Publications

Files in This Item:
File Description SizeFormat 
Prasad M_2020-2.pdf742.04 kBAdobe PDFThumbnail
View/Open
Show simple item record


Items in IR@NIPGR are protected by copyright, with all rights reserved, unless otherwise indicated.